AbbVie Net Change in Cash increased by 1140.5% to $4.16B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1292.6%, from -$349.00M to $4.16B. This is a positive signal — higher values indicate stronger performance for this metric.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q3 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.64B | -$3.65B | $3.31B | -$2.63B | -$2.49B | $4.53B | $5.25B | -$4.94B | -$5.87B | -$1.73B | -$349.00M | $1.29B | -$838.00M | -$400.00M | $4.16B |
| QoQ Change | — | -200.3% | +190.8% | -179.5% | +5.4% | +281.8% | +16.0% | -194.0% | -19.0% | +70.5% | +79.9% | +470.2% | -164.9% | +52.3% | >999% |
| YoY Change | — | — | -8.9% | — | +31.7% | +36.8% | +311.0% | — | -229.7% | — | -106.6% | +126.2% | +85.7% | +76.9% | >999% |